2595 results about "Single bond" patented technology

An organic electroluminescent device having a pair of electrodes and at least one organic layer interposed between the pair of electrodes, in which the at least one organic layer contains at least one compound represented by formula (I):

• • wherein, Z¹ and Z² each independently represent a nitrogen-containing aromatic six-membered ring coordinated to the platinum through a nitrogen atom; Q¹ represents a group of atoms necessary for forming, together with the —C—C—, a nitrogen-containing aromatic five-membered ring; L¹ represents a single bond or a divalent linking group; and n is 0 or 1.

A method for preparing a functionalized polymer comprising the steps of preparing a pseudo-living polymer by polymerizing conjugated diene monomer with a lanthanide-based catalyst, where said pseudo-living polymer is characterized by having greater than about 85 percent of the polymer in the cis microstructure and less than about 3 percent of the polymer is in the 1,2- or 3,4-microstructure, and reacting the pseudo-living polymer with at least one functionalizing agent defined by the formula (I) or (II)

where Z is a substituent that will react or interact with organic or inorganic fillers; R¹ is a single bond or a divalent organic group; R² is a monovalent organic group or a divalent organic group that forms a cyclic organic group with R¹³ or R¹⁴; R³ is a single bond, a divalent organic group, or a trivalent organic group that forms a cyclic organic group with R⁴ or R⁵; R¹³ is a single bond, a divalent organic group, or a trivalent organic group that forms a cyclic organic group with R² or R¹⁴; R⁴ is a monovalent organic group or a divalent organic group that forms a cyclic organic group with R³ or R⁵; R¹⁴ is a monovalent organic group or a divalent organic group that forms a cyclic organic group with R² or R¹³; and R⁵ is a monovalent organic group or a divalent organic group that forms a cyclic organic group with R³ or R⁴; with the proviso that each group attached to the imino carbon is attached via a carbon atom and R¹, R², R³, R⁴, R⁵, R¹³, R¹⁴ and Z are substituents that will not protonate a pseudo-living polymer.

A liquid crystal composition comprises liquid crystal molecules and an alignment promoter. The alignment promoter is represented by the formula (I). <paragraph lvl="0"><in-line-formula>(Hb-L1-)nBl (I) </in-line-formula>In the formula (I), Hb is an aliphatic group having 4 to 40 carbon atoms, an aromatic group having 6 to 40 carbon atoms or an aliphatic substituted oligosiloxanoxy group having 1 to 40 carbon atoms. L1 is a single bond or a divalent linking group, and n is an integer of 2 to 12. Bl is an n-valent group comprising at least two rings.

The present invention is a light emitting device material characterized by containing an anthracene compound represented by the following general formula (1) or general formula (3), and the present invention allows a light emitting device having high luminous efficiency and excellent durability.

(R¹ to R¹⁰ are a hydrogen atom, alkyl group, cycloalkyl group, heterocyclic group or the like. At least one of the R¹ to R¹⁰ is a substituent represented by the following general formula (2).)

(R¹¹ to R¹⁸ are a hydrogen atom, alkyl group and cycloalkyl group. X is an oxygen atom or sulfur atom, and Y is a single bond; arylene group or heteroarylene group. Any one of the R¹¹ to R¹⁸ is used for linking with Y, and α is used for linking with the anthracene skeleton.)

(R¹⁹ to R³⁷ are a hydrogen atom, alkyl group, cycloalkyl group, heterocyclic group or the like. n is 1 or 2. A is a heteroarylene group or arylene group. Any one of the R¹⁹ to R²⁷ and any one of the R²⁸ to R³⁷ are used for linking with A.)

A compound of formula (IV): O is a solid support; L is a linking group or a single bond; X' is selected from CO, NH, S, or O; A is O, S, NH, or a single bond; R2 and R3 are independently selected from: H, R, OH, OR, =O, =CH-R, =CH2, CH2-CO2R', CH2-CO2H, CH2-SO2R, O-SO2R, CO2R, COR, CN and there is optionally a double bond between C1 and C2 or C2 and C3; R6, R7, and R9 are independently selected from H, R, OH, OR, halo, nitro, amino, Me3Sn; R11 is either H or R; Q is S, O or NH; R10 is a nitrogen protecting group; and Y is a divalent group such that HY=R, and other related compounds and collections of compounds.

The present invention provides a novel compound having an excellent JNK inhibitory effect. That is, it provides a compound represented by the following formula, a salt thereof or a hydrate of them.

Wherein R¹ designates —(CO)_h—(NR^a)_j—(CR^b═CR^c)_k—Ar (wherein R^a, R^b and R^c each independently designate a hydrogen atom, a halogen atom, hydroxyl group, an optionally substituted C_1-6 alkyl group or the like;

• • Cy designates a 5- or 6-membered heteroaryl; and
  • V each independently designate the formula -L-X—Y (wherein L designates a single bond, an optionally substituted C_1-6 alkylene group or the like; X designates a single bond or the formula -A- (wherein A designates NR², O, CO, S, SO or SO₂) and so on; and Y designates a hydrogen atom, a halogen atom, nitro group or the like).

The light emitting device of the present invention relates to a light emitting device which is characterized in that it is a device with an emissive substance present between an anode and cathode, and which emits light by means of electrical energy, and said device has a least one type of compound denoted by (a) to (d) below. (a) A compound having a plurality of 1,7-phenanthroline skeletal structures (b) A benzoquinoline derivative (c) A spiro compound represented by general formula (1) A1 and A2 are each selected from single bonds, substituted or unsubstituted alkyl chains, ether chains, thioether chains, ketone chains and substituted or unsubstituted amino chains. However, A1<> A2. Z represents carbon or silicon. R1 to R16 are each selected from hydrogen, alkyl group, cycloalkyl group, aralkyl group, alkenyl group, cycloalkenyl group, alkynyl group, hydroxyl group, mercapto group, alkoxy group, alkylthio group, aryl ether group, aryl thioether group, aryl group, heterocyclic group, halogen, haloalkane, haloalkene, haloalkyne, cyano group, aldehyde group, carbonyl group, carboxyl group, ester group, carbamoyl group, amino group, nitro group, silyl group, siloxanyl group and a cyclic structure formed with an adjacent substituent. (d) A tetraphenylmethane derivative represented by general formula (2) R17 to R36 are each selected from hydrogen, alkyl group, cycloalkyl group, aralkyl group, alkenyl group, cycloalkenyl group, alkynyl group, hydroxyl group, mercapto group, alkoxy group, alkylthio group, aryl ether group, aryl thioether group, aryl group, heterocyclic group, halogen, haloalkane, haloalkene, haloalkyne, cyano group, aldehyde group, carbonyl group, carboxyl group, ester group, carbamoyl group, amino group, nitro group, silyl group, siloxanyl group and a cyclic structure formed with an adjacent substituent. However, at least one of R17 to R36 is selected from substituents represented by general formula (3). -X-Ar (3) X is a single bond or is selected from the following, and Ar denotes a condensed aromatic ring or heteroaromatic ring. In the case where X is phosphorus oxide, then Ar represents an aromatic hydrocarbon or heteroaromatic ring. n is an natural number.

An organic electroluminescent device having a pair of electrodes and at least one organic layer including a light-emitting layer interposed between the pair of electrodes, in which the organic layer contains at least one platinum complex compound having a quadridentate ligand containing a partial structure represented by formula (I):

• • wherein Z¹ represents a nitrogen-containing heterocycle coordinated to the platinum through a nitrogen atom; L¹ represents a single bond or a linking group; R¹, R³ and R⁴ each independently represent a hydrogen atom or a substituent; and R² represents a substituent.

The present invention relates to a novel two cyclic cinnamide compound and a pharmaceutical agent comprising the compound as an active ingredient. The two cyclic cinnamide compound represented by the general formula (I):

wherein represents a single bond or a double bond; Ar₁ represents a phenyl group or pyridinyl group that may be substituted with 1 to 3 substituents; R¹ and R² each represent a C1-6 alkyl group, a hydroxyl group, or the like; Z₁ represents a methylene group or vinylene group, which may be substituted with 1 or 2 substituents selected from Substituent Group A1, an oxygen atom, or an imino group that may be substituted with a substituent selected from Substituent Group A1; and p, q, and r each represent an integer of 0 to 2, which has an effect of reducing Aβ40 and Aβ42 production, and thus is particularly useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by Aβ such as Alzheimer's disease or Down's syndrome.

The present invention provides a solid catalyst component for the polymerization of olefins, comprising magnesium, titanium, a halogen and an electron donor, wherein said electron donor comprises at least one selected from the group consisting of polyol ester compounds of the formula (I): R₁CO—O—CR₃R₄-A-CR₅R₆—O—CO—R₂ (I) wherein, R₁ and R₂ groups, which may be identical or different, can be substituted or unsubstituted hydrocarbyl having 1 to 20 carbon atoms, R₃-R₆ groups, which may be identical or different, can be selected from the group consisting of hydrogen, halogen or substituted or unsubstituted hydrocarbyl having 1 to 20 carbon atoms, R₁-R₆ groups optionally contain one or more hetero-atoms replacing carbon, hydrogen atom or the both, said hetero-atom is selected from the group consisting of nitrogen, oxygen, sulfur, silicon, phosphorus and halogen atom, two or more of R₃-R₆ groups can be linked to form saturated or unsaturated monocyclic or polycyclic ring; A is a single bond or bivalent linking group with chain length between two free radicals being 1-10 atoms, wherein said bivalent linking group is selected from the group consisting of aliphatic, alicyclic and aromatic bivalent radicals, and can carry C₁-C₂₀ linear or branched substituents; one or more of carbon atom and/or hydrogen atom on above-mentioned bivalent linking group and substituents can be replaced by a hetero-atom selected from the group consisting of nitrogen, oxygen, sulfur, silicon, phosphorus, and halogen atom, and two or more said substituents on the linking group as well as above-mentioned R₃-R₆ groups can be linked to form saturated or unsaturated monocyclic or polycyclic ring.

An organic electroluminescent device having a pair of electrodes and at least one organic layer including a light-emitting layer interposed between the pair of electrodes, in which the organic layer contains at least one compound represented by formula (I):

wherein Z¹ and Z² each independently represent a nitrogen-containing heterocycle coordinated with the platinum through a nitrogen atom; Q¹ and Q² each independently represent a group bonded with the platinum through a carbon atom, an oxygen atom, a sulfur atom, a nitrogen atom or a phosphorous atom; Q¹ and Q² each represent a structure different from each other; L¹ and L² each independently represent a single bond or a linking group; and n represents 0 or 1.

Provided are an aromatic amine compound represented by the following Formula (1) and an organic electroluminescent element which has at least one organic thin film layer containing the above aromatic amine derivative in the form of a single component. The organic electroluminescent element described above has a high luminescent efficiency even at a low voltage and a long life. It can emit blue light even at high temperatures. In Formula (1), Ar¹ and Ar² each represent naphthyl and the like; Ar³ to Ar⁶ each represent phenyl, naphthyl, phenanthryl and the like; Ar⁷ to Ar¹⁰ each represent 1,4-phenylene and the like; L represents a single bond and the like; provided that the conditions of (1) and/or (2) are satisfied:

• (1) at least one of Ar³ to Ar⁶ is a condensed aryl group having 10 to 50 nuclear carbon atoms and
• (2) at least one of Ar¹ and Ar² is a condensed aryl group having 12 to 50 nuclear carbon atoms.

An organic electroluminescent device is provided and has at least one organic layer between a pair of electrodes. The organic compound contains a compound represented by the following formula (I):

Z¹ and Z² each represents a nitrogen-containing aromatic 6-membered ring coordinating to platinum atom at the nitrogen atom, Q represents a nitrogen-containing aromatic 5-membered ring having one or two nitrogen atoms, L¹ and L² each represents a single bond or a divalent group, and n represents 0 or 1.

The present invention relates to a compound represented by Formula (1) and a polymer obtained using the compound:

wherein R¹ is phenyl which may have substituents, Q¹ is hydrogen, halogen, alkyl having 1 to 10 carbon atoms, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclohexenyl or phenyl in which optional hydrogen may be replaced by halogen or alkyl having 1 to 5 carbon atoms,

and Q² is a group represented by Formula (2) wherein the code < represents a bonding point with silicon, l, m, n and p are independently 0, 1, 2 or 3, A¹ to A⁴ are independently a single bond, 1,4-cyclohexylene, 1,4-cyclohexenylene, a condensed ring group having 6 to 10 carbon atoms which is a divalent group, or 1,4-phenylene, Z⁰ to Z³ are independently a single bond, —CH═CR—, —C≡C—, —COO—, —OCO—, or alkylene having 1 to 20 carbon atoms, and Z⁴ is a single bond, —CH═CH—, —C≡C—, —COO—, —OCO—, or alkylene having 1 to 20 carbon atoms. And Y¹ in Formula (1) is the group defined in Claim 1.

The sulfonamide or carboamide derivatives of the formula (I) and a pharmaceutical composition which comprise them as an active ingredient:(wherein A ring, B ring is carbocyclic ring, heterocyclic ring; Z1 is -COR1, -CH=CH-COR1 etc.; Z2 is H, alkyl etc.; Z3 is single bond, alkylene; Z4 is SO2, CO; Z5 is alkyl, phenyl, heterocyclic ring etc.; R2 is CONR8, O, S, NZ6, Z7-alkylene, alkylene etc.; R3 is H, alkyl, halogen, CF3 etc.; R4 is H, (substituted) alkyl etc.; n, t is 1-4).The compounds of the formula (I) can bind to receptors of PGE2 and show antagonistic activity against the action thereof or agonistic activity. Therefore, they are considered to be useful as medicine for inhibition of uterine contraction, analgesics, antidiarrheals, sleep inducers, medicine for increase of vesical capacity or medicine for uterine contraction, cathartic, suppression of gastric acid secretion, antihypertensive or diuretic agents.

An organic dye used in a dye-sensitized solar cell is described, having general formula (1):

D-Sp1-Ch-Sp2-Acc-Y  (1)

wherein the groups D, Ch, Acc and Y are conjugate with each other, the group D is a donor group, the group Ch is a chromophore rendering low HOMO-LUMO gap or a polyaromatic chromophore, the group Acc is an acceptor group, the group Y is an anchoring group, and each of Sp1 and Sp2 represents a single bond or a spacer group allowing conjugation between the groups D and Ch or between the groups Ch and Acc.

The compound represented by formula (I)

(wherein ringA is cyclic group which may have a substituent(s), Q is alkyl which may have a substituent(s) or cyclic ring which may have a substituent(s), ringD is cyclic ring which may have a substituent(s), W is a single bond or a spacer of which main chain has an atom number of 1-4, Y is a spacer of which main chain has an atom number of 1-4.), a salt thereof, an N-oxide thereof or a solvate thereof, or a prodrug thereof Since the compounds represented by formula (I), a salt thereof, an N-oxide thereof or a solvate thereof, or a prodrug thereof have the affinity to MBR, they are useful for the prevention and/or treatment for disease caused by stress.

An organic electroluminescent element comprising a pair of electrodes and at least one organic compound layer including a luminescent layer between the pair of electrodes, wherein at least one of the at least one organic compound layer comprises a compound represented by the following formula (I):

wherein in formula (I), Q₁ represents an atomic group necessary for forming an unsaturated ring together with the carbon atom; Q₂ and Q₃ each independently represent an atomic group necessary for forming an unsaturated ring together with the nitrogen atom; X represents a partial structure comprising an atom that is linked to the platinum atom; A₁ represents a linking group; B₁, B₂ and B₃ each independently represent a linking group or a single bond; m and n each independently represent 0 or 1; and at least one of m and n is not 1.

The present invention relates to a polymerizable compound represented by a formula (I). The present invention provides a polymerizable compound, a polymerizable composition, a polymer, and an optically anisotropic article that are capable of obtaining an optical film having a low melting point, having excellent solubility, capable of being manufactured at low cost, and capable of uniform polarized light conversion across a broad wavelength region. [In formula: Y¹ to Y⁶ are independently a chemical single bond, —O—, —O—C(═O)—, —C(═O)—O— etc.; G¹ and G² are independently a divalent C1-C20 aliphatic group etc.; Z¹ and Z² are independently C2-C10 alkenyl group that is substituted with a halogen atom etc.; A^x is a C2-C30 organic group that includes at least one aromatic ring selected from a group consisting of an aromatic hydrocarbon ring and an aromatic hetero ring; A^y is a hydrogen atom, a C1-C20 alkyl group, a C2-C20 alkenyl group, a C3-C12 cycloalkyl group etc.; A¹ is a trivalent aromatic group etc.; A² and A³ are independently a divalent C6-C30 aromatic group etc.; and Q¹ is a hydrogen atom, or a C1-C6 alkyl group etc.]